Skip to Content

u25 (Briviact 25 mg)

Generic Name: brivaracetam

Pill with imprint u25 is Gray, Elliptical / Oval and has been identified as Briviact 25 mg. It is supplied by UCB, Inc..

Briviact is used in the treatment of seizures; epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Briviact 25 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).

Images for u25

Briviact 25 mg u25

Briviact

Generic Name
brivaracetam
Imprint
u25
Strength
25 mg
Color
Gray
Size
9.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Pyrrolidine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
5 - Some potential for abuse
Labeler / Supplier
UCB, Inc.
National Drug Code (NDC)
50474-0470
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, betadex, lactose anhydrous, magnesium stearate, magnesium silicate, polyethylene glycol 3350, titanium dioxide, ferric oxide yellow, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "u25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.